JP Morgan Maintains Overweight on Zai Lab, Lowers Price Target to $32

Benzinga Newsdesk www.benzinga.com Negative 86.8%

Neg 86.8% Neu 0% Pos 0%

JP Morgan analyst Anupam Rama maintains Zai Lab (NASDAQ:ZLAB) with a Overweight and lowers the price target from $39 to $32.